Inspection Hot Topics

Size: px
Start display at page:

Download "Inspection Hot Topics"

Transcription

1 Inspection Hot Topics QP Forum, Trinity College Ciara Turley, Inspector, HPRA 16 th April 2015

2 Content Hot topics = common deficiencies Data based on 100 inspections conducted in 2014 Inspections of non-sterile and sterile finished product manufacturing sites, API manufacturing sites and third country manufacturers 15/04/2015 2

3 Critical Deficiency A critical deficiency is one which has produced, or leads to a significant risk of producing, either a product which is harmful to the human patient, or in the case of veterinary product, harmful to an animal or which could result in a harmful residue in a food-producing animal 15/04/2015 3

4 Major Deficiency A non-critical deficiency is one which has produced or may produce a product, which does not comply with its marketing authorisation; or which indicates a major deviation from EU Good Manufacturing Practice; or (within EU) which indicates a major deviation from the terms of the MIA or which indicates a failure to carry out satisfactory procedures for release of batches or (within EEA) a failure of the Qualified Person to fulfil their legal duties; or a combination of several other deficiencies, none of which on their own may be major, but which may together represent a major deficiency and should be explained and reported as such. 15/04/2015 4

5 Other Deficiency A deficiency, which cannot be classified as either critical or major, but which indicates a departure from good manufacturing practice. 15/04/2015 5

6 Breakdown of deficiencies cited in critical major other /04/2015 6

7 Quality system deficiencies critical major other /04/2015 7

8 Deviation / CAPA deficiencies Lack of investigation detail documented Lack of consideration of reoccurrence No CAPAs raised Root cause not stated or lack of supporting evidence for conclusions Impact on other batches / equipment not considered Lack of effectiveness checks Inadequate trending Lack of definition, particularly planned deviations and events 15/04/2015 8

9 Example of Quality System deficiencies For Deviation X relating to a faulty magnetic stirrer, the report did not include details of what had caused the stirrer to malfunction and if the repair had dealt with this Deviation Y related to breaking of vials in the in-feed zone and at the crimping machine. There was no evidence in the file that training recommended for engineers and a microbiologist had been performed. Deviations X, Y and Z related to cartons for product X (two instances) and product Y sticking together. The recommendation for each deviation was that Logistics would take the matter up with the carton supplier. There was no record that this had been done. Deviation Notification X referred to an issue with the belt on the filling line a resulted in ampoule breakage. A new belt was installed again. There was no investigation or discussion of the root cause which was said to be due to the assembly of the belt. 15/04/2015 9

10 Examples of Quality System deficiencies The root cause analysis was heavily weighted towards poor asepsis of the operator in question for that isolated incident. This was not considered a satisfactory assessment to determine the actual root cause of the contamination event. Deviation reports included a section for reporting whether the deviation had occurred previously; the company were only entering deviations in this section if they had occurred within the same calendar year. The root cause of the deviation (that a valve had not been completely closed during micronisation) did not have a preventive action assigned to prevent re-occurrence. For deviation X the company had considered the impact isolated to one batch even though the same solution had been used in the manufacture of sixteen batches in total. There was no documented risk assessment to support this conclusion 15/04/

11 Examples of Quality System deficiencies The release disposition of batch X was not considered appropriate as: There was inadequate data to show that the process was successfully revalidated and could consistently produce product that met specification. There was inadequate data to support the rationale for the assigned root cause of the out of specification blend assay There was no manufacturing investigation completed to determine the root cause at the time of batch release There was no comparison of revalidation data with results from previous validation batches 15/04/

12 Premises and equipment deficiencies critical major other /04/

13 Examples of Premises and Equipment deficiencies With respect to the re-qualification of load X The justification to accept qualification loads with breaches in the sterilization band during the hold phase was not considered acceptable. The approach did not consider the suitability of the cycle or ability of the autoclave to control such loads e.g. min load for X which contained a piece of tubing. A number of items used appeared to have been previously subjected to sterilization. The controls in place to ensure they represented a normal load were not clearly described. E.g. stopper and crimp bags with multiple taped punctures. Comparison to the original PQ was not performed. 15/04/

14 Examples of Premises and Equipment deficiencies The cleaning and storage of equipment was deficient in that: The size, design and condition of the wash room was deficient. The room was small and cleaned equipment was stored in close proximity to dirty equipment The wash sinks were visually stained and contaminated as were some of the surrounding walls The sinks were not flush and sealed against the walls There was a particularly contaminated recessed area observed above the sink Some balances and scales stored in another room had not been stored in a clean state as white residues and streak marks were observed on some of these items together with sticky residues which remained after the removal of obsolete calibration stickers. 15/04/

15 Examples of Premises and Equipment deficiencies Management of equipment maintenance at the site was deficient in that: Unplanned maintenance activities had not been recorded and there was no requirement for these activities to be recorded under the company s quality management system at the time of the inspection; It was observed that the company s investigations into the high number of incidences of rogue tablets had not considered that non-recording of unplanned maintenance activities may have been a contributing factor in this regard. 15/04/

16 Examples of Premises and Equipment deficiencies The company relied on previous equipment qualification studies to determine the possibility of rogues entering a finished batch rather than challenging the packaging lines again during investigation to verify that the systems for identification and rejection of the rogues remained effective. 15/04/

17 Production deficiencies critical major other sterile media fill visual inspection data integrity line clearance inspection cleaning validation general 15/04/

18 Example of Production deficiencies Incoming receipt checks for raw materials were inadequate as: The Approved Vendors Listing (AVL) did not specify all actors in within the supply chain, e.g. suppliers The vendor / manufacturer address of product stored in the warehouse did not match the address listed on the AVL AVLs were generated from information on labels of material stored in the warehouse rather than from the approved sites listed by the planning / purchasing department The company had sourced a number of batches of active substance through a supplier that refused to disclose the actual manufacturer of the active substance. The material was used in the manufacture of aseptically prepared finished medicinal product. 15/04/

19 Example of Production deficiencies Labeling practices were considered to increase the overall risk to product in that: It was accepted practice at the facility to place material labels on container lids unfixed for a period on time. This was considered to add undue risk to the process as labeling mixups would not be readily detected as SAP was utilized to manage material from this point. Rejected material within the dispensary and warehouse was not physically segregated. They were not clearly marked as rejected. It was noted that reject materials were blocked on SAP but this was used for on hold status also. The warehouse staging room was cluttered with a high volume of rejected material outside of the on hold area. 15/04/

20 Example of Production deficiencies Aseptic process controls were considered deficient. It noted that vials unloaded from the Lyos, were not afforded appropriate protection from the background environment during transfer to the capping station, which was classified by the company as Grade A, but which was considered Grade B background by the inspector. There was no validated raised or displaced stopper detection system in place. Reliance was placed on a visual check prior to capping and vials were permitted to be stored in this area for a period up to 48 hours. 15/04/

21 Example of Production deficiencies During set-up activities on the it was noted that: component contact parts were exposed for excessive periods of time in the background environment which was classified by the company as a Grade A room, which was considered the background Grade B to the Grade A critical zone and were permitted to be carried from the autoclave trolley across this room prior to transfer into the critical zone In general component parts were considered to have been handled excessively and not in a manner conducive to good asepsis Sporocidal agents were not proactively included in the disinfectant rotation in the site s sanitisation programme, 15/04/

22 Example of Production deficiencies The manner in which set up was conducted was considered cumbersome and due to the positioning of the product lines, the set up was made much more difficult to perform with a satisfactory level of asepsis due to the fact that when attempting to complete the aseptic connection, there was not a clear line of sight or a clear path to enable the operator to make a quick and clean connection. Two media fill failures had occurred where growth promotion testing post filling failed. No growth had been obtained and the investigation had not determined a root cause for this failure. 15/04/

23 Example of Production deficiencies The particulate monitoring system for both the oncology and non oncology suites had been removed for repair from both areas and had not been replaced at the time of inspection. During the intervening period a mobile monitoring device was introduced but it was only possible to perform particulate monitoring in one location, the vial infeed location, leaving the filling zone without any particulate monitoring for an extended period. There was a report for 5cfu/plate for a settle plate obtained in the sterility testing laboratory on the day after sterility testing of the batch. There was no discussion of any relevant implications of this result within the investigation report. 15/04/

24 Outsourced Activities 37 of 47 deficiencies related to technical agreements. Absence of agreements Lack of designation of responsibilities Absence of key issues e.g. Timelines regarding reporting of significant deviations 15/04/

25 Examples of deficiencies With regard to contractual arrangements with a QP the job description (dated August 2009) was not reflective of the current responsibilities, approximately 48 SOPs were read and understood over two days in The contract QP was not formally required to read relevant quality summary documents prior to recommencing QP activities following long periods off site e.g. quarterly management reviews, PQRs etc. 15/04/

26 Learning Review these elements as part of self inspection programme Review investigations to ensure root cause, impact assessment and CAPA well defined and sufficient evidence included Review equipment and production deficiencies within your own company processes Ensure technical agreements in place and defined review the content as part of PQR. 15/04/

Deficiencies found in Inspections and QP Responsibilities

Deficiencies found in Inspections and QP Responsibilities Deficiencies found in Inspections and QP Responsibilities Ciara Turley, HPRA Inspector QP Forum, Trinity College, Dublin 25 th April 2017 Dublin Key QP Responsibilities Chapter 1, 1.4 (xv) Medicinal products

More information

Common deficiencies/ hot topics

Common deficiencies/ hot topics Common deficiencies/ hot topics Non-sterile & API manufacture Oisín Daly GMP Conference 7 February 2017 Dublin Non-sterile finished product manufacture Deficiencies by Eudralex Vol. 4 GMP guide > 60% 3

More information

Inspection of API Manufacturers & Update on Registration Process

Inspection of API Manufacturers & Update on Registration Process Inspection of API Manufacturers & Update on Registration Process Catherine Neary, GMP Inspector GMP Conference 7 February 2017 Dublin Presentation Contents HPRA Inspection Programme for API Manufacturers

More information

GMP Inspection Deficiencies Review of Deficiencies Observed in 2013.

GMP Inspection Deficiencies Review of Deficiencies Observed in 2013. GMP Inspection Deficiencies 2013 Review of Deficiencies Observed in 2013. Executive Summary The most frequently encountered defect categories raised over the previous five years have remained relatively

More information

Trinity College Dublin QP Forum 2017 Tuesday 25 th April

Trinity College Dublin QP Forum 2017 Tuesday 25 th April Trinity College Dublin QP Forum 2017 Tuesday 25 th April HPRA QUESTIONS & ANSWERS 1. What is the approach being taken for audit of contamination control strategies as per chapters 3 & 5? What is the current

More information

Annex 4. Guidance on good manufacturing practices: inspection report. Background

Annex 4. Guidance on good manufacturing practices: inspection report. Background Annex 4 Guidance on good manufacturing practices: inspection report Background The need for revision of the Guidance on good manufacturing practices: inspection report (World Health Organization (WHO)

More information

Outsourcing - managing risks and opportunities over which you now have less control

Outsourcing - managing risks and opportunities over which you now have less control Outsourcing - managing risks and opportunities over which you now have less control Kevin O Donnell, PhD PDA Meeting, Dublin 22 nd November 2018 Slide 2 Typical Examples The key GMP Requirements & Guidance

More information

Product quality reviews

Product quality reviews Product quality reviews Document valid from: 07.11.2017 Document number: I-SMI.TI.14 Version no. 05 Classification: Public Replaced document: I-SMI.TI.14_04 dated: 14.08.2014 Root QMI documents: - Referenced

More information

Prequalification of Medicines Programme

Prequalification of Medicines Programme Prequalification of Medicines Programme SOP 408.4 Annex A WHO PUBLIC INSPECTION REPORT Finished Product Manufacturer WHO PUBLIC INSPECTION REPORT (WHOPIR) Finished Product Manufacturer Part 1: General

More information

SITE MASTER FILE For MHRA

SITE MASTER FILE For MHRA ABC CO., LTD. For MHRA Prepared by Date Approved by Date Verified by Date Document No.: SMF, Version No: 01, Effective Date: 09/05/06 Document No.: SMF Version No.: 01 Effective Date: 09/05/06 Page 2 of

More information

Overview of Regulatory Requirements for API and Formulations

Overview of Regulatory Requirements for API and Formulations Overview of Regulatory Requirements for API and Formulations Sangeeta Sardesai 4-Dec-2010 Definition - Regulatory Requirement The restrictions, licenses, and laws applicable to a product or business, imposed

More information

AAMI Quality Systems White Paper

AAMI Quality Systems White Paper AAMI s White Paper Comparison of 21 CFR Part 820 to ISO 13485:2016 February 2017, Updated February 2018 AUTHORS Seb Clerkin, GMP Advisory Services Nicola Martin, Owner, Nicola Martin Consulting Jack Ward,

More information

Materials Management Traceability, CEPs and managing non-conforming sites

Materials Management Traceability, CEPs and managing non-conforming sites Materials Management Traceability, CEPs and managing non-conforming sites IMB Information Day, 14 th October 2010 Dr Cormac Dalton Inspector 13-Oct-10 Slide 1 Managing Supply Supply Demand Supply chain

More information

GMP Requirements. Gabriel Kaddu, Senior GMP Specialist Promoting the Quality of Medicines Program (PQM) U.S. Pharmacopeial Convention (USP)

GMP Requirements. Gabriel Kaddu, Senior GMP Specialist Promoting the Quality of Medicines Program (PQM) U.S. Pharmacopeial Convention (USP) GMP Requirements Gabriel Kaddu, Senior GMP Specialist Promoting the Quality of Medicines Program (PQM) U.S. Pharmacopeial Convention (USP) 2016. ALL RIGHTS RESERVED. Outline GMP Procedures and standards

More information

The World Bank. Aide Memoire for use during GMP inspections

The World Bank. Aide Memoire for use during GMP inspections The World Bank e for use during GMP inspections The World Bank Procurement of Health Sector Goods Contact persons: 0 1. General information about the manufacturer Name of manufacturer Physical address

More information

Contents. Contents (13) 1 Production (23)

Contents. Contents (13) 1 Production (23) 1 Production (23) 1.A Sanitation (27) 1.A.1 Organisational prerequisites (27) 1.A.2 Sources of contamination (28) 1.A.3 Responsibilities and implementation (29) 1.B Personnel hygiene (31) 1.B.1 Clothing

More information

Prequalification Team WHO PUBLIC INSPECTION REPORT Vaccine Manufacturer

Prequalification Team WHO PUBLIC INSPECTION REPORT Vaccine Manufacturer Part 1: General information Name of Manufacturer Production Block Physical address Contact address Prequalification Team WHO PUBLIC INSPECTION REPORT Vaccine Manufacturer. Clean Utilities in the Basement.

More information

Association of American Railroads Quality Assurance System Evaluation (QASE) Checklist Rev. 1/12/2017

Association of American Railroads Quality Assurance System Evaluation (QASE) Checklist Rev. 1/12/2017 Company: Prepared By: Date: Changes from previous version highlighted in yellow. Paragraph Element Objective Evidence 2.1 Objective of Quality Assurance Program 2.2 Applicability and Scope 2.3 QA Program

More information

Review Validation of aseptic processes for pharmaceuticals

Review Validation of aseptic processes for pharmaceuticals OPEM www.opem.org Oriental Pharmacy and Experimental Medicine 2010 10(4), 231-238 DOI 10.3742/OPEM.2010.10.4.231 Review Validation of aseptic processes for pharmaceuticals Lincy Joseph*, Mathew George

More information

Inspections, Compliance, Enforcement, and Criminal Investigations

Inspections, Compliance, Enforcement, and Criminal Investigations Seite 1 von 10 Inspections, Compliance, Enforcement, and Criminal Investigations Dabur Oncology PLC hhsbluebird Department of Health and Human Services Warning Letter Public Health Service Food and Drug

More information

The APIC Audit Programme Version 5, July 2017

The APIC Audit Programme Version 5, July 2017 The APIC Audit Programme Version 5, July 2017 Table of contents 1 General 2. APIC Audit Programme 3 The Auditors 3.1 Educational Background and Experience 3.2 Auditor Training Courses for Certification

More information

Documenta tion and Records

Documenta tion and Records Documenta tion and Records Page 1 of 30 Training Outcome of the Module: After completing this module, you will be able to: Recognize the importance of procedures Recognize the importance of record keeping

More information

Product Quality Review: Overview and Feedback from Inspection

Product Quality Review: Overview and Feedback from Inspection Product Quality Review: Overview and Feedback from Inspection GMP/Market Compliance Information Day October 23 rd 2008 Lorraine Nolan Acting Inspection Manager IMB Slide 1 Scope of Presentation Overview

More information

New GDP Guidelines - Implementation

New GDP Guidelines - Implementation New GDP Guidelines - Implementation Alfred Hunt, Inspector Wholesale Distribution Conference 11 th November 2014 New GDP Guidelines 2013/C 63/01-8 th September 2013 2013/C 343/01-5 th November 2013 2 1994

More information

Data Integrity: Production Environment

Data Integrity: Production Environment Data Integrity: Production Environment MANUAL AND AUTOMATED SYSTEMS Ciara Turley GMP Conference 12 th November 2014 Content GMP Guide requirements and application to processing equipment Security Audit

More information

Good Manufacturing Practices Purpose and Principles of GMP. Tony Gould

Good Manufacturing Practices Purpose and Principles of GMP. Tony Gould Good Manufacturing Practices Purpose and Principles of GMP Tony Gould Why GMP? Provides a high level assurance that medicines are manufactured in a way that ensures their safety, efficacy and quality Medicines

More information

Change Control Overview

Change Control Overview Change Control Overview Kelly Thomas Atlantic Technical and Validation Services Copyright 2014 by Atlantic Technical and Validation Services, LLC. 1 Session Outline Discuss Regulations Governing Change

More information

PIC/S GUIDE TO GOOD PRACTICES FOR THE PREPARATION OF MEDICINAL PRODUCTS IN HEALTHCARE ESTABLISHMENTS

PIC/S GUIDE TO GOOD PRACTICES FOR THE PREPARATION OF MEDICINAL PRODUCTS IN HEALTHCARE ESTABLISHMENTS PHARMACEUTICAL INSPECTION CONVENTION PHARMACEUTICAL INSPECTION CO-OPERATION SCHEME PE 010-3 1 October 2008 PIC/S GUIDE TO GOOD PRACTICES FOR THE PREPARATION OF MEDICINAL PRODUCTS IN HEALTHCARE ESTABLISHMENTS

More information

Regulatory Requirements & Recent Changes, including expectations for APIs & IMPs

Regulatory Requirements & Recent Changes, including expectations for APIs & IMPs Regulatory Requirements & Recent Changes, including expectations for APIs & IMPs Neil Raw - GMP Inspector Richard Andrews - Operations Manager 11 th November 2008 Programme: Regulatory Requirements Neil

More information

Subpart B Organization and Personnel, 21 CFR Responsibilities of the quality control unit.

Subpart B Organization and Personnel, 21 CFR Responsibilities of the quality control unit. FDA inspections continue to focus on CGMP violations related to basic GMP controls. A survey of Warning Letters issued in 2013 on CMC (Chemistry / Manufacturing / Controls) violations reveals an emphasis

More information

Working Party on Control of Medicines and Inspections. Final Version of Annex 16 to the EU Guide to Good Manufacturing Practice

Working Party on Control of Medicines and Inspections. Final Version of Annex 16 to the EU Guide to Good Manufacturing Practice Version 8 (final) EUROPEAN COMMISSION ENTERPRISE DIRECTORATE-GENERAL Single market, regulatory environment, industries under vertical legislation Pharmaceuticals and cosmetics Brussels, July 2001 Working

More information

The EDQM Inspection Programme

The EDQM Inspection Programme The EDQM Inspection Programme Prague, 20 September 2017 Dr Sotirios Paraschos, Inspector Certification of Substances Department, EDQM Overview: EDQM Inspection Programme in the frame of Certification Procedure

More information

Vendor Qualification Survey

Vendor Qualification Survey 1200 West 96 th St Minneapolis, MN 55431 Ph: 952-888-7900 Fax: 952-888-2719 Vendor Qualification Survey Vendor Information Company Name: Date: Address: City: Phone Number: email address: Product or Service

More information

Guide for Distributors of Medical Devices

Guide for Distributors of Medical Devices Guide for Distributors of Medical Devices IA-G0004-1 8 FEBRUARY 2018 This guide does not purport to be an interpretation of law and/or regulations and is for guidance purposes only. CONTENTS 1 SCOPE 3

More information

UNICEF s Quality Assurance System for Procurement of Finished Pharmaceutical Products

UNICEF s Quality Assurance System for Procurement of Finished Pharmaceutical Products UNICEF s Quality Assurance System for Procurement of Finished Pharmaceutical Products UNICEF Industry Consultation with Manufacturers and Suppliers of Finished Pharmaceutical Products 29 th 30 th September

More information

Quality Manual QM -07 Approval: D. Wheeler. AARD Spring & Stamping Quality Manual. Quality Manual. Page 1 of 24

Quality Manual QM -07 Approval: D. Wheeler. AARD Spring & Stamping Quality Manual. Quality Manual. Page 1 of 24 Quality Manual Page 1 of 24 ISO 9001:2015 Standard to Quality Manual Section Matrix ISO 9001:2015 Quality Manual Section 1 Scope 1 Scope 1.1 General 4 Context of the organization 4 Quality management system

More information

Guide to Quality System for General Sale Wholesale Distributors

Guide to Quality System for General Sale Wholesale Distributors Guide to Quality System for General Sale Wholesale Distributors IA-G0038-5 20 DECEMBER 2017 This guide does not purport to be an interpretation of law and/or regulations and is for guidance purposes only.

More information

UNCONTROLLED DOCUMENT

UNCONTROLLED DOCUMENT Rheem Manufacturing Company Fort Smith, Arkansas Original Release: 4/06/09 Revision Date: 10/25/16 Quality Management System D. Presley 05 1 of 1 Manual Contents A. Johnson 10/25/16 0 Section Title Revision

More information

Quality Assessment & GMP Similarities & Differences

Quality Assessment & GMP Similarities & Differences Quality Assessment & GMP Similarities & Differences EMEA, Monday 26 th October 2009 Cormac Dalton Inspector Irish Medicines Board Date 12-Oct-09 Slide 1 Content Overview of commonalities & differences

More information

Update to the Manufacturing Principles for Medicinal Products

Update to the Manufacturing Principles for Medicinal Products Update to the Manufacturing Principles for Medicinal Products Michel Lok, Head of Office Robyn Oatey, GMP Auditor, Medicines Office of Manufacturing Quality Therapeutic Goods Administration Introduction

More information

EUROPEAN COMMISSION DIRECTORATE-GENERAL FOR HEALTH AND FOOD SAFETY. EudraLex. Volume 4

EUROPEAN COMMISSION DIRECTORATE-GENERAL FOR HEALTH AND FOOD SAFETY. EudraLex. Volume 4 EUROPEAN COMMISSION DIRECTORATE-GENERAL FOR HEALTH AND FOOD SAFETY Ref. Ares(2015)4234460-12/10/2015 Medicinal products quality, safety and efficacy Brussels, 12 October 2015 EudraLex Volume 4 EU Guidelines

More information

A Compilation of WHO GMP Audit Points

A Compilation of WHO GMP Audit Points A Compilation of WHO GMP Audit Points Collected from WHOPIR of 28 companies Part VIII of VIII Current article Part VIII Support QMS Prepared and Submitted By: Edited by : A. Jwalakanth B.Pharm, MBA (Aus)

More information

SCHEDULE M-III [See Rule 76]

SCHEDULE M-III [See Rule 76] SCHEDULE M-III [See Rule 76] QUALITY MANAGEMENT SYSTEM FOR NOTIFIED MEDICAL DEVICES AND IN-VITRO DIAGNOSTICS 1. General This schedule specifies requirements for a quality management system that shall be

More information

Supersedes Division Name Revision No. 0 Export Division Page No. 1 of 9

Supersedes Division Name Revision No. 0 Export Division Page No. 1 of 9 Page No. 1 of 9 Control Status 1.0 Purpose To lay down a procedure for conducting GMP inspection and report writing for issue of Written Confirmation for for medicinal products for human. 2.0 Scope This

More information

UNICEF Quality Assurance in the procurement of medicines

UNICEF Quality Assurance in the procurement of medicines UNICEF Quality Assurance in the procurement of medicines Peter S. Jakobsen October 2008 Quality Assurance Centre SUPPLY DIVISION 2 Today s presentation addresses 3 questions: How do UNICEF manage quality

More information

USP Chapter 823 USP 32 (old) vs. USP 35 (new)

USP Chapter 823 USP 32 (old) vs. USP 35 (new) USP Chapter 823 USP 32 (old) vs. USP 35 (new) Sally W. Schwarz, MS, BCNP Research Associate Professor of Radiology Washington University School of Medicine St. Louis, MO Why USP Chapter ? FDA has

More information

Review of HPRA Draft Guide to Distribution of Medical Devices, including in vitro diagnostic Medical Devices

Review of HPRA Draft Guide to Distribution of Medical Devices, including in vitro diagnostic Medical Devices Review of HPRA Draft Guide to Distribution of Medical Devices, including in vitro diagnostic Medical Devices Ref: IA-G0004-x Summary DCC Vital welcomes the new draft guidance which will provide clarity

More information

(Information) INFORMATION FROM EUROPEAN UNION INSTITUTIONS, BODIES, OFFICES AND AGENCIES EUROPEAN COMMISSION

(Information) INFORMATION FROM EUROPEAN UNION INSTITUTIONS, BODIES, OFFICES AND AGENCIES EUROPEAN COMMISSION 21.3.2015 EN Official Journal of the European Union C 95/1 II (Information) INFORMATION FROM EUROPEAN UNION INSTITUTIONS, BODIES, OFFICES AND AGENCIES EUROPEAN COMMISSION Guidelines of 19 March 2015 on

More information

External Providers Quality Requirements.

External Providers Quality Requirements. External Providers Quality Requirements. 1. General Requirements. 1.1 Introduction. This document establishes the quality assurance requirements for external providers of process, product and service pursuant

More information

Guide to Quality Defect Investigation Reports

Guide to Quality Defect Investigation Reports Guide to Quality Defect Investigation Reports SUR-G0020-2 22 NOVEMBER 2017 This guide does not purport to be an interpretation of law and/or regulations and is for guidance purposes only. 1 SCOPE This

More information

Sterilizing and Bioburden Filter Risk Assessment in Vaccine Processes as part of QRM

Sterilizing and Bioburden Filter Risk Assessment in Vaccine Processes as part of QRM Sterilizing and Bioburden Filter Risk Assessment in Vaccine Processes as part of QRM DCVMN Workshop, Hyderabad, 4-8 April 2016 G. Somasundaram Associate Director - Technology Management Overview Key Regulatory

More information

Aseptic Process Validation

Aseptic Process Validation Aseptic Process Validation IMB GMP Information Seminar 27 th September 2012 Gerard Sheridan, Inspector Date Insert on Master Slide Slide 1 Overview Guidance Best Practices Common Deficiencies Slide 2 Aseptic

More information

POLYCRAFT INCORPORATED QUALITY MANUAL Quality Manual QM -10 Approval: D. Wheeler.

POLYCRAFT INCORPORATED QUALITY MANUAL Quality Manual QM -10 Approval: D. Wheeler. Polycraft, Inc. QM - 10 Title: Polycraft, Inc. Quality Manual Copy Approval: D. Wheeler This Quality Manual is the sole property of Polycraft, Inc. and intended for exclusive use by the organization. This

More information

Wholesaling & Distribution & the GMPs

Wholesaling & Distribution & the GMPs Wholesaling & Distribution & the GMPs Presented by Bryan Wright 11 th July 2016 Overview Wholesaling & distribution of Medicines (FPs) in the EU New EU GDP Guidelines Expectations How complicated can the

More information

Wholesaling & Distribution & the GMPs

Wholesaling & Distribution & the GMPs Wholesaling & Distribution & the GMPs Presented by Bryan Wright 11 th July 2016 Overview Wholesaling & distribution of Medicines (FPs) in the EU New EU GDP Guidelines Expectations How complicated can the

More information

Emcure Pharmaceuticals Limited 3/3/16

Emcure Pharmaceuticals Limited 3/3/16 1 of 7 05/06/2016 8:22 AM U.S. Food and Drug Administration Protecting and Promoting Your Health Emcure Pharmaceuticals Limited 3/3/16 Department of Health and Human Services Public Health Service Food

More information

MHRA GMP Inspection Deficiency Data Trend 2016

MHRA GMP Inspection Deficiency Data Trend 2016 MHRA GMP Inspection Deficiency Data Trend 2016 Introduction The GMDP Inspectorate has improved the way of gathering the inspection deficiency data for 2016. The new data trending can allow industries to

More information

Regional GMP Strengthening Workshop for Indian Pharmaceutical Manufacturers and State Regulators

Regional GMP Strengthening Workshop for Indian Pharmaceutical Manufacturers and State Regulators Regional GMP Strengthening Workshop for Indian Pharmaceutical Manufacturers and State Regulators Focused on GMP in production of Active Pharmaceutical Ingredients and Oral Solid Dosage Forms Organized

More information

ASTM D10-F02 Workshop FDA Regulatory Perspective. Patrick Weixel FDA Center for Devices and Radiological Health

ASTM D10-F02 Workshop FDA Regulatory Perspective. Patrick Weixel FDA Center for Devices and Radiological Health ASTM D10-F02 Workshop FDA Regulatory Perspective Patrick Weixel FDA Center for Devices and Radiological Health 1 FDA Regulatory Perspective Focus of talk: Use of Standards Auditing Packaging Process Deficiencies

More information

Most Common Deficiencies Found. Dr Florence Benoit-Guyod Head of the inspection section Certification of Substances Department

Most Common Deficiencies Found. Dr Florence Benoit-Guyod Head of the inspection section Certification of Substances Department Most Common Deficiencies Found by EDQM Dr Florence Benoit-Guyod Head of the inspection section Certification of Substances Department Overview Fact & Figures Main deficiencies Conclusion 2 Inspection figures

More information

Computerised Systems. Inspection Expectations. Paul Moody, Inspector. 18/10/2013 Slide 1. ISPE GAMP COP Ireland Meeting, Dublin, 17 th October 2013

Computerised Systems. Inspection Expectations. Paul Moody, Inspector. 18/10/2013 Slide 1. ISPE GAMP COP Ireland Meeting, Dublin, 17 th October 2013 Computerised Systems Inspection Expectations ISPE GAMP COP Ireland Meeting, Dublin, 17 th October 2013 Paul Moody, Inspector Slide 1 Presentation Contents Brief Introduction to the IMB Regulatory References

More information

Quality Manual. AARD Spring & Stamping Quality Manual

Quality Manual. AARD Spring & Stamping Quality Manual Quality Manual Page 1 of 25 AARD Spring & Stamping QM/5.0 Title: QM 5.0 AARD Spring & Stamping Quality Manual Copy Approval Date: 1/27/2011 Reviewer(s): Sign / Print Title Date Dan Wheeler Document Originator

More information

THE GMP HANDBOOK ANNEXES. g o o d m a n u fac t u r i n g p r ac t i c e. quality systems for the pharmaceutical industry.

THE GMP HANDBOOK ANNEXES. g o o d m a n u fac t u r i n g p r ac t i c e. quality systems for the pharmaceutical industry. THE GMP HANDBOOK g o o d m a n u fac t u r i n g p r ac t i c e quality systems for the pharmaceutical industry Ke y2 C om pl ia nc e AB by Anna Lundén ANNEXES Key2Compliance AB Annexes - Content Annexes

More information

Prequalification Team Inspection services WHO PUBLIC INSPECTION REPORT (WHOPIR) Finished Product Manufacturer. Tablets

Prequalification Team Inspection services WHO PUBLIC INSPECTION REPORT (WHOPIR) Finished Product Manufacturer. Tablets Prequalification Team Inspection services WHO PUBLIC INSPECTION REPORT (WHOPIR) Finished Product Manufacturer Part 1: information about the inspection Name of manufacturer Physical address production departments

More information

GUIDE TO GOOD MANUFACTURING PRACTICE FOR MEDICINAL PRODUCTS

GUIDE TO GOOD MANUFACTURING PRACTICE FOR MEDICINAL PRODUCTS PHARMACEUTICAL INSPECTION CONVENTION PHARMACEUTICAL INSPECTION CO-OPERATION SCHEME GUIDE TO GOOD MANUFACTURING PRACTICE FOR MEDICINAL PRODUCTS PH 1/97 (Rev. 3), 15 January 2002 ANNEX 15 QUALIFICATION AND

More information

Introduction to Medicines Inspections Technical Updates:

Introduction to Medicines Inspections Technical Updates: Introduction to Medicines Inspections Technical Updates: GMP inspections of Active Pharmaceutical Ingrédients and Finished Pharmaceutical Products (including Reproductive Health Products) Vimal Sachdeva,

More information

SUPPLIER QUALITY ASSESSMENT

SUPPLIER QUALITY ASSESSMENT Supplier Organization Name: Supplier Number: Street Address: Date of This Audit: City, State, Zip Code: Date of Last Audit: Country: of Employees: Main Phone Number: of Buildings/Size: Fax Number: Principal

More information

NMT Specialized Machining Inc & NMT General Machining Inc AS 9100 Rev C Quality Systems Manual

NMT Specialized Machining Inc & NMT General Machining Inc AS 9100 Rev C Quality Systems Manual NMT Specialized Machining Inc & NMT General Machining Inc AS 9100 Rev C Quality Systems Manual 290 Shoemaker Street Kitchener, Ontario Canada N2E 3E1 Table of Contents Introduction 5 Documentation Scheme..

More information

Prequalification Team WHO PUBLIC INSPECTION REPORT Vaccine Manufacturer

Prequalification Team WHO PUBLIC INSPECTION REPORT Vaccine Manufacturer Prequalification Team WHO PUBLIC INSPECTION REPORT Vaccine Manufacturer Part 1: General information Name of Manufacturer / Iksan Plant Unit number Production Block Physical address Contact person and email

More information

Quality Risk Management

Quality Risk Management Quality Risk Management Audit Expectations and Observations Matthew Davis Lead Auditor Office of Manufacturing Quality, TGA CAPSIG 4 th May 2011 www.tga.gov.au 2 QRM - TGA Expectations and Observations

More information

WHO GMP for Pharmaceutical Products: Main Principles

WHO GMP for Pharmaceutical Products: Main Principles 제약업계의품질경영 : 원칙과필수요소 (Quality management in the medicines industry: philosophy and essential elements) 1 In the medicines industry at large, quality management is usually defined as the aspect of the management

More information

Quality Assurance in Pharmaceutical and Biotech Industries as Per Regulatory Guidelines

Quality Assurance in Pharmaceutical and Biotech Industries as Per Regulatory Guidelines Human Journals Review Article January 2017 Vol.:8, Issue:2 All rights are reserved by Chagi Venkatesh et al. Quality Assurance in Pharmaceutical Biotech Industries as Per Regulatory Guidelines Keywords:

More information

Correspondence Between ISO 13485:2016 and 21 CFR Part 820 QMS Requirements

Correspondence Between ISO 13485:2016 and 21 CFR Part 820 QMS Requirements Correspondence Between and 21 CFR Part 820 QMS Requirements 10411 Corporate Drive, Suite 102, Pleasant Prairie, WI 53158 262.842.1250 262.842.1240 info@rcainc.com rcainc.com 2 4 Quality Management System

More information

Correspondence between ICMED criteria and ISO 13485: 2012

Correspondence between ICMED criteria and ISO 13485: 2012 Annexure A (Informative) Correspondence between ICMED 13485 criteria and ISO 13485: 2012 Green Font is additional ICMED 13485 criteria requirement. Additional ICMED 13485 criteria Requirements are also

More information

Quality Management System MANUAL. SDIX, LLC Headquarters: 111 Pencader Drive Newark, Delaware 19702

Quality Management System MANUAL. SDIX, LLC Headquarters: 111 Pencader Drive Newark, Delaware 19702 Quality Management System MANUAL SDIX, LLC Headquarters: 111 Pencader Drive Newark, Delaware 19702 Doc. No. G5500 Rev. 11 Status : APPROVED Effective: 09/07/2017 Page 2 of 32 Quality Manual Table of Contents

More information

Risk Analysis: myths, confusions and real sense

Risk Analysis: myths, confusions and real sense Risk Analysis: myths, confusions and real sense Dr. Alexander Fedotov, Director of Invar-project Company, Moscow, Russia fedotov@invar-project.ru www.invar-project.ru 1. What is risk analysis? 2. GMP EU

More information

Webinar Expert Module 3: GMP Inspections Dupont

Webinar Expert Module 3: GMP Inspections Dupont Webinar Expert Module 3: GMP Inspections Dupont 26 January & 9 February 2018 GOP-Innovations your Partner for Practical Training and e-learning Milenko Pavičić Pharmaceutical microbiologist, trainer, coach

More information

EudraLex. Part I1 Chapter 6: Quality Control

EudraLex. Part I1 Chapter 6: Quality Control EudraLex The Rules Governing Medicinal Products in the European Union Volume 4 EU Guidelines tofor Good Manufacturing Practice for Medicinal Products for Human and Veterinary Use Part I1 Chapter 6: Quality

More information

Unit 208 Assist with the manufacture and assembly of medicinal products

Unit 208 Assist with the manufacture and assembly of medicinal products Element 1 Element 2 Assist with the preparation and packaging Assist with the completion of the manufacturing and assembly process 341 342 Element 1 Element 2 Assist with the preparation and packaging

More information

EUROPEAN COMMISSION HEALTH AND CONSUMERS DIRECTORATE-GENERAL. EudraLex. The Rules Governing Medicinal Products in the European Union

EUROPEAN COMMISSION HEALTH AND CONSUMERS DIRECTORATE-GENERAL. EudraLex. The Rules Governing Medicinal Products in the European Union Ref. Ares(2014)968036-28/03/2014 EUROPEAN COMMISSION HEALTH AND CONSUMERS DIRECTORATE-GENERAL Health systems and products Medicinal products quality, safety and efficacy Brussels, 28 March 2014 EudraLex

More information

14620 Henry Road Houston, Texas PH: FX: WEB: QUALITY MANUAL

14620 Henry Road Houston, Texas PH: FX: WEB:  QUALITY MANUAL 14620 Henry Road Houston, Texas 77060 PH: 281-447-3980 FX: 281-447-3988 WEB: www.texasinternational.com QUALITY MANUAL ISO 9001:2008 API Spec Q1, 9th Edition API Spec 8C 5 Th Edition MANUAL NUMBER: Electronic

More information

Inspection. Implementation of ICH Q8, Q9, Q10

Inspection. Implementation of ICH Q8, Q9, Q10 Implementation of ICH Q8, Q9, Q10 International Conference on Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use Outline Aim of - as a key part of the regulatory

More information

Prequalification of Medicines Programme. WHO PUBLIC INSPECTION REPORT (WHOPIR) API Manufacturer

Prequalification of Medicines Programme. WHO PUBLIC INSPECTION REPORT (WHOPIR) API Manufacturer Prequalification of Medicines Programme. WHO PUBLIC INSPECTION REPORT API Manufacturer WHO PUBLIC INSPECTION REPORT (WHOPIR) API Manufacturer Part 1: General information Name of Manufacture Unit number

More information

QP Supplier Quality Requirements Manual. Purchasing. Dearborn Inc. Revision: E Page 1 of PURPOSE

QP Supplier Quality Requirements Manual. Purchasing. Dearborn Inc. Revision: E Page 1 of PURPOSE Page 1 of 8 1.0 PURPOSE 1.1 The purpose of this manual is to have a single document which conveys the minimum quality requirements and manufacturing practices expected of suppliers for value added products

More information

Supplier Quality Requirements SQR-1.0 Rev. 3

Supplier Quality Requirements SQR-1.0 Rev. 3 Supplier Quality Requirements Rev. 3 Approved By: Brian Brown, Quality Manager The current issue of this document is maintained on LSP Technologies, Inc. s Internet Web Site at http://www.lspt.com/resources-supplier_requirements.asp.

More information

GMP for ATMP. Advanced Therapy Medicinal Products Key2Compliance AB

GMP for ATMP. Advanced Therapy Medicinal Products Key2Compliance AB GMP for ATMP Advanced Therapy Medicinal Products 2018 Key2Compliance AB 1 Content Background and regualtory requirements GMP Walkthrough Quality Risk Management 2018 Key2Compliance AB 2 Background and

More information

WHO guidelines on quality risk management

WHO guidelines on quality risk management Annex 2 WHO guidelines on quality risk management 1. Introduction 62 1.1 Background and scope 62 1.2 Principles of quality risk management 64 2. Glossary 67 3. Quality risk management process 70 3.1 Initiating

More information

Feedback from Inspection Programme

Feedback from Inspection Programme Feedback from Inspection Programme Wholesale Distribution Conference 8 th February 2017 Darren Scully Health Products Distribution Manager Wholesale distribution overview wholesale distribution procure

More information

Process development and basic GMP

Process development and basic GMP Process development and basic GMP Aulton Chapter 45, handouts Specification, stability, inprocess controls and validation Product development Process development Critical Product Qualities issues Critical

More information

Environmental Monitoring of Aseptic Processing Areas - 1

Environmental Monitoring of Aseptic Processing Areas - 1 Environmental Monitoring of Aseptic Processing Areas - 1 A war against an invisible enemy DCVMN - Víctor Maqueda - May 30, 31, June 1 2016 1 Training Course Agenda Overview of Environmental Monitoring

More information

Planning for and Managing FDA Inspections. Focus: 21 CFR, Part 820

Planning for and Managing FDA Inspections. Focus: 21 CFR, Part 820 Planning for and Managing FDA Inspections Focus: 21 CFR, Part 820 Information, Preventive Action and Strategy 1 The Authority behind Inspections The Safe Medical Devices Act of 1990 (the SMDA), enacted

More information

EUROPEAN COMMISSION ENTERPRISE AND INDUSTRY DIRECTORATE-GENERAL. EudraLex The Rules Governing Medicinal Products in the European Union

EUROPEAN COMMISSION ENTERPRISE AND INDUSTRY DIRECTORATE-GENERAL. EudraLex The Rules Governing Medicinal Products in the European Union EUROPEAN COMMISSION ENTERPRISE AND INDUSTRY DIRECTORATE-GENERAL Consumer goods Pharmaceuticals Brussels, 25 October 2005 EudraLex The Rules Governing Medicinal Products in the European Union Volume 4 EU

More information

AS 9100 Rev C Quality Systems Manual AS-050C-QM

AS 9100 Rev C Quality Systems Manual AS-050C-QM AS 9100 Rev C Quality Systems Manual AS-050C-QM Innovative Control Systems, Inc. 10801 N. 24 th Ave. Suite 101-103 Phoenix, AZ 85029 U.S.A. www.icsaero.com +01-602-861-6984 VOICE +01-602-588-9440 FAX Table

More information

EU Guidance / Q&A. Greg McGurk, GMP Manager (acting) GMP Conference. 7 February 2017 Dublin

EU Guidance / Q&A. Greg McGurk, GMP Manager (acting) GMP Conference. 7 February 2017 Dublin EU Guidance / Q&A Greg McGurk, GMP Manager (acting) GMP Conference 7 February 2017 Dublin TPN Manufacture Q&A TPN Guidance Proposed at IWG that working group be formed to draft guidance Several adverse

More information

Quality Assurance Policy and Procedures

Quality Assurance Policy and Procedures 650 Montana Ave, Suite A Las Cruces, NM 88001 (575) 522-0430 www.rmgovernmentservices.com Quality Assurance Policy and Procedures PURPOSE. The purpose of this policy is to outline the quality assurance

More information

MONZA ST5 Project. Alberto Penati Patheon Monza EU Engineering Director. The world leader in serving science

MONZA ST5 Project. Alberto Penati Patheon Monza EU Engineering Director. The world leader in serving science MONZA ST5 Project Alberto Penati Patheon Monza EU Engineering Director The world leader in serving science SUMMARY 1. Monza Site Overview 2. Design Data 3. Philosophy and approach on installation 4. Challenges

More information

INS QA Programme Requirements

INS QA Programme Requirements Specification Date: 20/3/17 INS QA Programme Requirements UNCONTROLLED WHEN PRINTED Author: J Cooch AUTHORISATION Date: 20/3/17 A Brown Owner: J Cooch (Signature) N.B. only required for hard copy If issued

More information

Process Validation (PV): Designing an Effective PV Program. Mike Porter Compliance Consultant Commissioning Agents Inc.

Process Validation (PV): Designing an Effective PV Program. Mike Porter Compliance Consultant Commissioning Agents Inc. Process Validation (PV): Designing an Effective PV Program Mike Porter Compliance Consultant Commissioning Agents Inc. (CAI) 24Apr2013 Agenda Process Validation Background Stage 1: Process Design Stage

More information

UPGRADE ASSESSMENT CHECKLIST

UPGRADE ASSESSMENT CHECKLIST Checklist Instructions : Prior to auditing each element, the auditor shall review the documentation and mark a 0 in each box where functions /departments are referenced. As each function/department is

More information

Document Type: Main Process: Revision Level: Page: POLICY QUALITY ASSURANCE 3 1 of 6 Process Owner Title:

Document Type: Main Process: Revision Level: Page: POLICY QUALITY ASSURANCE 3 1 of 6 Process Owner Title: POLICY QUALITY ASSURANCE 3 1 of 6 Process Owner A. SCOPE This document contains requirements for conducting business with Tri Star Metals, LLC and its customers. It is applicable to suppliers that provide

More information